NCT02140684

Exhaled Nitric Oxide in Asthma Management

Exhaled Nitric Oxide in Asthma Management: a Retrospective Real-life Observational Evaluation of the Use of Exhaled Nitric Oxide Measurements for Asthma Management in a UK Primary Care Population

• Status: Suspended
• Phase: —
• Study type: Observational
• Enrollment: 400 (estimated)
• Sponsor: Research in Real-Life Ltd · Network
• Sex: All
• Age: 6 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

This study will compare the absolute and relative effectiveness of managing real-life asthma with and without the use of NIOX MINO® and NIOX Flex® to measure exhaled nitric oxide (eNO) as a marker of underlying airway inflammation to guide appropriate management. As exhaled nitric oxide responds rapidly to environmental changes and can act as a marker of underlying inflammation it is proposed that incorporating eNO monitoring into routine asthma management treatment allows strategies to be more accurately tailored to the patients needs, increasing the probability of good asthma control.

Conditions

• Asthma

Interventions

Type	Name	Description
DEVICE	eNO monitoring	Patient undergoing review with eNO monitored using either NIOX MINO® and NIOX Flex®

Timeline

• Start date: 2012-03-01
• Primary completion: 2015-01-01
• Completion: 2015-01-01
• First posted: 2014-05-16
• Last updated: 2014-05-16

Locations

1 site across 1 country: United Kingdom